SCHEMBL21940779

SCHEMBL21940779

CC(C)c1ccc(C2CCCCCC2)cc1OC(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.41
HTR2A P28223 1/20 0.39
PDK2 Q15119 1/20 0.36
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
PDE4A P27815 2/20 0.34
PDE4B Q07343 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34
KCNK3 O14649 1/20 0.34
KCNK9 Q9NPC2 1/20 0.34
APP P05067 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
DRD2 P14416 1/20 0.33
DRD1 P21728 1/20 0.33
DRD4 P21917 1/20 0.33
DRD5 P21918 1/20 0.33
DRD3 P35462 1/20 0.33
BACE1 P56817 1/20 0.33
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21939667 1.00 S1PR1 (0.41) S1PR1HTR2APDK2SLC6A2SLC6A4
SCHEMBL15577035 0.87 HTR2A (0.53) HTR2ASLC6A2SLC6A4PDE4B
SCHEMBL22313381 0.81 LMNA (0.40) PDE4APDE4BPDE4CPDE4DACMSD
SCHEMBL21872201 0.78 HTR2A (0.41) HTR2APDK2APPACMSDBACE1
SCHEMBL10192316 0.77 HTR2A (0.51) HTR2ASLC6A2SLC6A4PDE4B
SCHEMBL20073696 0.77 QDPR (0.44) HTR2APDE4APDE4BPDE4CPDE4D
SCHEMBL13256359 0.76 HTR2A (0.42) HTR2APDK2APPACMSDBACE1
SCHEMBL21872202 0.75 APP (0.43) PDK2APPACMSDBACE1EPHX2
SCHEMBL21872033 0.75 APP (0.43) PDK2APPACMSDBACE1EPHX2
SCHEMBL21872092 0.75 APP (0.43) PDK2APPACMSDBACE1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131144-A1 AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS PHENEX-FXR GMBH (DE) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131144-A1 AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS NR1H2, NR1H3, NR1H4 S1PR1 272/4885HTR2A 1490/4885PDK2 2117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.